ATE107703T1 - Bakterielle antigene, antikörper, impfstoffe und deren herstellung. - Google Patents
Bakterielle antigene, antikörper, impfstoffe und deren herstellung.Info
- Publication number
- ATE107703T1 ATE107703T1 AT87903113T AT87903113T ATE107703T1 AT E107703 T1 ATE107703 T1 AT E107703T1 AT 87903113 T AT87903113 T AT 87903113T AT 87903113 T AT87903113 T AT 87903113T AT E107703 T1 ATE107703 T1 AT E107703T1
- Authority
- AT
- Austria
- Prior art keywords
- gbs
- polysaccharide
- vaccines
- antibodies
- production
- Prior art date
Links
- 229960005486 vaccine Drugs 0.000 title abstract 4
- 239000000427 antigen Substances 0.000 title abstract 3
- 102000036639 antigens Human genes 0.000 title abstract 3
- 108091007433 antigens Proteins 0.000 title abstract 3
- 230000001580 bacterial effect Effects 0.000 title abstract 2
- 150000004676 glycans Chemical class 0.000 abstract 4
- 229920001282 polysaccharide Polymers 0.000 abstract 4
- 239000005017 polysaccharide Substances 0.000 abstract 4
- 102000018697 Membrane Proteins Human genes 0.000 abstract 1
- 108010052285 Membrane Proteins Proteins 0.000 abstract 1
- 102000004142 Trypsin Human genes 0.000 abstract 1
- 108090000631 Trypsin Proteins 0.000 abstract 1
- 239000002775 capsule Substances 0.000 abstract 1
- 238000003776 cleavage reaction Methods 0.000 abstract 1
- 230000002255 enzymatic effect Effects 0.000 abstract 1
- 230000003053 immunization Effects 0.000 abstract 1
- 238000002649 immunization Methods 0.000 abstract 1
- 238000003018 immunoassay Methods 0.000 abstract 1
- 108010011519 keratan-sulfate endo-1,4-beta-galactosidase Proteins 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 230000007017 scission Effects 0.000 abstract 1
- 239000012588 trypsin Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
- A61K39/092—Streptococcus
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
- C07H3/06—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
- C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
- C12N9/2468—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1) acting on beta-galactose-glycoside bonds, e.g. carrageenases (3.2.1.83; 3.2.1.157); beta-agarase (3.2.1.81)
- C12N9/2471—Beta-galactosidase (3.2.1.23), i.e. exo-(1-->4)-beta-D-galactanase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/04—Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
- C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
- C12Y302/01023—Beta-galactosidase (3.2.1.23), i.e. exo-(1-->4)-beta-D-galactanase
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
- G01N33/56944—Streptococcus
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Wood Science & Technology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Cell Biology (AREA)
- Analytical Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Tropical Medicine & Parasitology (AREA)
- Mycology (AREA)
- Virology (AREA)
- Veterinary Medicine (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Epidemiology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US85284086A | 1986-04-16 | 1986-04-16 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE107703T1 true ATE107703T1 (de) | 1994-07-15 |
Family
ID=25314361
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT87903113T ATE107703T1 (de) | 1986-04-16 | 1987-04-14 | Bakterielle antigene, antikörper, impfstoffe und deren herstellung. |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP0302887B1 (de) |
| JP (2) | JP2754000B2 (de) |
| AT (1) | ATE107703T1 (de) |
| CA (1) | CA1305918C (de) |
| DE (1) | DE3750139T2 (de) |
| DK (1) | DK175487B1 (de) |
| WO (1) | WO1987006267A1 (de) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5648241A (en) | 1989-09-15 | 1997-07-15 | The General Hospital Corporation | Conjugate vaccine against group B streptococcus |
| IL95578A (en) * | 1989-09-15 | 1998-08-16 | Gen Hospital Corp | Conjugate vaccine formed from a polysaccharide and a c protein of b-streptococcus |
| JPH05502157A (ja) * | 1989-09-18 | 1993-04-22 | ブリガム アンド ウィメンズ ホスピタル | グループb連鎖球菌3型莢膜オリゴ糖の酵素学的産生及び回収 |
| CA2059693C (en) * | 1991-01-28 | 2003-08-19 | Peter J. Kniskern | Polysaccharide antigens from streptococcus pneumoniae |
| CA2059692C (en) * | 1991-01-28 | 2004-11-16 | Peter J. Kniskern | Pneumoccoccal polysaccharide conjugate vaccine |
| DE69231663T2 (de) * | 1991-03-12 | 2001-08-23 | The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services | Polysaccharid-protein-konjugate |
| FR2682388B1 (fr) * | 1991-10-10 | 1995-06-09 | Pasteur Merieux Serums Vacc | Procede de preparation d'un oligoside par depolymerisation d'un polyoside issu d'un agent pathogene, oligoside ainsi obtenu et son utilisation notamment comme agent vaccinal. |
| EP0667787B1 (de) * | 1992-09-24 | 2001-07-18 | Brigham And Women's Hospital | Gruppe b streptococcus typ ii und typ v polysaccharid-protein konjugate als impfstoffe |
| ZA937034B (en) * | 1992-09-24 | 1995-06-23 | Brigham & Womens Hospital | Group B streptococcus type II and type V polysaccharide-protein conjugate vaccines |
| AU722078B2 (en) * | 1992-11-02 | 2000-07-20 | Brigham And Women's Hospital | Conjugate vaccine against group B Streptococcus |
| IL107458A0 (en) * | 1992-11-02 | 1994-02-27 | Gen Hospital Corp | Conjugate vaccine against group b streptococcus |
| DK0699689T3 (da) * | 1994-08-19 | 2000-05-08 | Nestle Sa | Forgrenet polysaccharid, mikroorganisme, der producerer dette, samt præparater indeholdende disse |
| US5866132A (en) * | 1995-06-07 | 1999-02-02 | Alberta Research Council | Immunogenic oligosaccharide compositions |
| US6284884B1 (en) | 1995-06-07 | 2001-09-04 | North American Vaccine, Inc. | Antigenic group B streptococcus type II and type III polysaccharide fragments having a 2,5-anhydro-D-mannose terminal structure and conjugate vaccine thereof |
| US5695768A (en) * | 1995-06-07 | 1997-12-09 | Alberta Research Council | Immunostimulating activity of Streptococcus pneumoniae serotype 8 oligosaccharides |
| KR19990007777A (ko) * | 1995-06-07 | 1999-01-25 | 듀크두플레시스 | 면역성 및 면역자극성 올리고당 조성물 및 이를 제조하고 이용하는 방법 |
| BR9813071A (pt) * | 1997-10-17 | 2000-08-15 | Nestle Sa | Espécie de bactéria láctica |
| CA2777837C (en) * | 2008-10-27 | 2017-07-11 | Novartis Ag | Purification method |
| CN115572716B (zh) * | 2022-09-30 | 2023-06-16 | 云南沃森生物技术股份有限公司 | 抗iii型b群链球菌荚膜多糖单克隆抗体及杂交瘤细胞株 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4207414A (en) * | 1978-08-16 | 1980-06-10 | President And Fellows Of Harvard College | Polysaccharide antigens |
| US4413057A (en) * | 1980-04-14 | 1983-11-01 | Merck & Co., Inc. | Group B streptococcal capsular polysaccharides |
| US4356263A (en) * | 1980-06-09 | 1982-10-26 | President And Fellows Of Harvard College | Method of making a polysaccharide vaccine |
-
1987
- 1987-04-14 JP JP62502728A patent/JP2754000B2/ja not_active Expired - Fee Related
- 1987-04-14 DE DE3750139T patent/DE3750139T2/de not_active Expired - Lifetime
- 1987-04-14 WO PCT/US1987/000845 patent/WO1987006267A1/en not_active Ceased
- 1987-04-14 EP EP87903113A patent/EP0302887B1/de not_active Expired - Lifetime
- 1987-04-14 AT AT87903113T patent/ATE107703T1/de not_active IP Right Cessation
- 1987-04-15 CA CA000534749A patent/CA1305918C/en not_active Expired - Lifetime
- 1987-12-15 DK DK198706566A patent/DK175487B1/da not_active IP Right Cessation
-
1996
- 1996-03-26 JP JP8094730A patent/JPH08277298A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| DK175487B1 (da) | 2004-11-08 |
| DE3750139T2 (de) | 1994-10-06 |
| JPH01500561A (ja) | 1989-03-01 |
| WO1987006267A1 (en) | 1987-10-22 |
| EP0302887B1 (de) | 1994-06-22 |
| DK656687A (da) | 1987-12-15 |
| EP0302887A1 (de) | 1989-02-15 |
| EP0302887A4 (de) | 1989-11-20 |
| JP2754000B2 (ja) | 1998-05-20 |
| CA1305918C (en) | 1992-08-04 |
| JPH08277298A (ja) | 1996-10-22 |
| DE3750139D1 (de) | 1994-07-28 |
| DK656687D0 (da) | 1987-12-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE107703T1 (de) | Bakterielle antigene, antikörper, impfstoffe und deren herstellung. | |
| NO308413B1 (no) | Antigen blanding, DNA-segment som koder for et antigen, rekombinant vektor og vertscelle som innbefatter DNA-segmentet samt anvendelser av et antigen | |
| FI883876A0 (fi) | Menetelmä rokotteen valmistamiseksi streptokokki-infektioita vastaan | |
| NZ223009A (en) | Oligosaccharides containing d-ribose d-ribitol and phosphate units mimicing haemophilus influenzae type b antigens | |
| NO975434L (no) | Fremgangsmåte for fremstilling av influensa hemagglutinin multivalente vaksiner | |
| ATE267258T1 (de) | Impfstoffe für das respiratorische-synzytial- virus mit nuklein säuren | |
| ATE7761T1 (de) | Impfstoff und herstellungsverfahren. | |
| ATE105334T1 (de) | Schimaerische glykoproteine enthaltende immunogenische abschnitte von menschlichem parainfluenzavirus typ 3. | |
| ES8404186A1 (es) | "un procedimiento para obtener al menos un polipeptido que presenta la antigenicidad de los antigenos e del virus de la hepatitis b". | |
| ATE7855T1 (de) | Herstellung von virusantigenen. | |
| DE3175677D1 (en) | Polysaccharide antigen from streptococcus and vaccines | |
| FI950378A0 (fi) | Immuunitesti kollageenin tai kollageenifragmenttien havaitsemiseksi | |
| FI924457A0 (fi) | Kompositioner och behandlingsfoerfarande foer lunginflammation i djur | |
| HUT52819A (en) | Process for producing polypeptides suitable for diagnosing mycoplasmic contamination of swine, by way of recombinant dna technique | |
| DE69130955D1 (de) | Adhesin-oligosaccharid-impfstoffkonjugate für -i(haemophilus influenza) | |
| ATE149569T1 (de) | Verfahren zur herstellung von impfstoffen oder toxoiden | |
| ZA796476B (en) | Feline infectious peritonitis vaccine | |
| DK421486A (da) | Polydisperse native pseudomonas-flagella(h)-antigener (fag) og fremgangsmaade til deres udvinding | |
| Nutter | Antigens of Pasteurella tularensis: preparative procedures | |
| Hinz | Heat‐stable Antigenic Determinants of Haemophilus paragallinarum | |
| FR2517967B1 (de) | ||
| SE8403929L (sv) | Rekombinant-dna-molekyl, transformerade mikroorganismer och forfarande for framstellning av penicillin v-amidas | |
| FR2655853B1 (fr) | Procede de culture intensive, in vitro, de souches de babesia divergens, procede de preparation d'exoantigenes et vaccin contenant ces antigenes. | |
| Padyukov et al. | Detection of noncapsular pneumococcal antigens. | |
| Sela et al. | Immunological Approaches to the Vaccines of the Future. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| EELA | Cancelled due to lapse of time |